Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmigo Resources Regulatory News (AMGO)

Share Price Information for Amigo Resources (AMGO)

Share Price is delayed by 15 minutes
Get Live Data
2.50    0.125 (5.26%)
Bid:
2.25
Ask:
2.75
Spread: 0.50 (22.222%)
Market Cap: £29.75m
AMGO Live PriceLast checked at - London Stock Exchange

Intraday Amigo Resources Share Chart

Board Changes

6 Jun 2022 17:08

RNS Number : 8954N
Amigo Holdings PLC
06 June 2022
 

6 June 2022

 

Amigo Holdings PLC

("Amigo" or the "Company")

 

Board Changes

Amigo Holdings PLC (LSE: AMGO), a provider of guarantor loans in the UK, announces the following Board changes.

 

Chief Financial Officer

Danny Malone will join the Board as Chief Financial Officer ("CFO") and as an Executive Director. His appointment as an Executive Director is subject to approval under the Senior Managers' Regime, by the Financial Conduct Authority. Danny has been acting as Interim CFO since February 2022.

 

Danny has a wealth of experience, including at board level in a variety of financial services companies. A qualified chartered accountant, he has held senior management and executive board level positions with Everyday Loans Limited as Chief Executive Officer, Finance Director and founder, Citifinancial Europe PLC as Chief Executive Officer and Chief Financial Officer, and Avco Trust PLC as Finance Director. He has also served as Chief Executive of Perch Group. 

 

He is currently Non-Executive Chair of Floan Limited, a start-up fintech online loan company servicing travel agents, and a Non-Executive Director of The Personal Finance Centre Limited, both non-listed companies.

 

There are no additional matters that would require disclosure under LR 9.6.13R (1) to (6) in relation to this appointment.

 

Senior Independent Director

Maria Darby-Walker, an existing Non-Executive Director, has been appointed as Senior Independent Director of the Company, subject to approval under the Senior Managers' Regime, by the Financial Conduct Authority.

 

Following the appointment of Danny, the total number of Directors on Amigo's Board will consist of three independent Non-Executive Directors, including the Chair, and two Executive Directors.

 

 

Jonathan Roe, Chair said: "We are delighted that Danny Malone has agreed to join Amigo's Board as an Executive Director and CFO. He proved his credentials for the role whilst acting as Interim CFO and brings to the Board a wealth of business acumen and financial management expertise gained from working in the consumer finance sector."

"I am also delighted that Maria Darby-Walker is taking on the role of Senior Independent Director. The whole executive team has moved mountains to get us to our current position and deserve wholesome praise. In like terms, our Non-Executive Directors, Maria Darby-Walker and Michael Bartholomeusz, since they joined the Board some 18 months ago, have been unstinting with their time, care and effort to help guide Amigo through the issues the company has faced."

Danny Malone, CFO said: "I am very happy to be part of a refreshed Board at Amigo. I am looking forward to helping Amigo overcome the remaining hurdles of returning to lending and building a successful new business for an underserved customer base."

 

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014. The person responsible for this announcement is Roger Bennett, Company Secretary.

Additional Information

This announcement is not intended to, and does not, constitute or form part of any offer, invitation, or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell, or otherwise dispose of, any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to this announcement or otherwise.

This announcement constitutes notice by Amigo Luxembourg S.A. (the "Issuer") to the holders of the Issuer's 7.625% Senior Secured Notes due 2024 (for the notes issued pursuant to Rule 144A of the United States Securities Act of 1933, ISIN: XS1533928468 and Common Code: 153392846; for the notes issued pursuant to Regulation S of the United States Securities Act of 1933, ISIN: XS1533928625 and Common Code: 153392862) (the "Notes") issued pursuant to pursuant to Section 4.03(a)(3) of an indenture dated January 20, 2017 among, inter alia, the Issuer, the guarantors named therein and U.S. Bank Trustees Limited, as trustee and security agent. Amigo Holdings PLC is the indirect parent company of the Issuer. This announcement shall constitute a "Report" to holders of the Notes.

Company

Amigo Holdings PLC investors@amigo.me

Kate Patrick Head of Investor Relations

Roger Bennett Company Secretary

 

Media enquiries Amigoloans@lansons.com 

Tom Baldock 07860 101715

Ed Hooper 07783 387713

-ENDS-

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASSIFMMEESESM
Date   Source Headline
29th Jan 202010:05 amRNSForm 8.5 (EPT/RI)- Amigo Holdings plc
29th Jan 20208:17 amRNSForm 8.5 (EPT/RI) Amigo Holdings Plc
28th Jan 202012:50 pmBUSForm 8.3 - AMIGO HOLDINGS PLC
28th Jan 202011:18 amRNSForm 8.3 - Amigo Holdings plc
28th Jan 202010:32 amRNSForm 8.5 (EPT/RI)- Amigo Holdings plc
28th Jan 20208:55 amRNSForm 8.5 (EPT/RI) Amigo Holdings Plc
27th Jan 20204:53 pmPRNForm 8.3 - Amigo Holdings
27th Jan 20207:00 amRNSStrategic Review and Statement from Richmond Group
13th Jan 20202:02 pmRNSHolding(s) in Company
10th Jan 20205:20 pmRNSHolding(s) in Company
10th Jan 20205:18 pmRNSHolding(s) in Company
10th Jan 20204:00 pmRNSDirector and PDMR Dealing
7th Jan 20203:54 pmRNSHolding(s) in Company
13th Dec 20198:00 amRNSCommittee Changes
11th Dec 20196:29 pmRNSDirector/PDMR Dealing
9th Dec 20197:00 amRNSBoard Changes
5th Dec 20197:00 amRNSFree Float
2nd Dec 20197:00 amRNSHolding(s) in Company
2nd Dec 20197:00 amRNSDirector/PDMR Shareholding
29th Nov 20198:14 amRNSRichmond Group Board Representation
28th Nov 20197:02 amRNSHalf-year Report
28th Nov 20197:00 amRNSClarification on Regulatory Update
27th Nov 20191:57 pmRNSRegulatory Update
22nd Nov 20197:00 amRNSRichmond Group Board Representation
21st Nov 201911:15 amRNSHolding(s) in Company
13th Nov 20193:17 pmRNSHolding(s) in Company
8th Nov 20195:15 pmRNSDirector/PDMR Shareholding
29th Oct 20193:45 pmRNSHolding(s) in Company
10th Oct 20195:30 pmRNSDirector and PDMR dealing
10th Oct 20197:00 amRNSNotice of Results
4th Oct 20196:04 pmRNSFree Float
23rd Sep 20195:06 pmRNSDirector/PDMR Shareholding
23rd Sep 201911:45 amRNSDirector/PDMR Shareholding
12th Sep 201910:56 amRNSDirector/PDMR Shareholding
6th Sep 20194:41 pmRNSSecond Price Monitoring Extn
6th Sep 20194:35 pmRNSPrice Monitoring Extension
4th Sep 20197:00 amRNSHolding(s) in Company
2nd Sep 20194:35 pmRNSPrice Monitoring Extension
2nd Sep 20198:00 amRNSDirector/PDMR Shareholding
30th Aug 201911:48 amRNSHolding(s) in Company
29th Aug 20197:00 amRNS1st Quarter Results
28th Aug 20194:40 pmRNSSecond Price Monitoring Extn
28th Aug 20194:35 pmRNSPrice Monitoring Extension
22nd Aug 201912:07 pmRNSSecond Price Monitoring Extn
22nd Aug 201912:02 pmRNSPrice Monitoring Extension
16th Aug 201912:08 pmRNSSecond Price Monitoring Extn
16th Aug 201912:02 pmRNSPrice Monitoring Extension
14th Aug 201912:07 pmRNSSecond Price Monitoring Extn
14th Aug 201912:02 pmRNSPrice Monitoring Extension
8th Aug 201912:08 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.